7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2007-12-31 2007-09-30 
      
    		                                                                 
      cash flows from operating activities:
    		                                                                 
      net income
    		5,654,000 8,678,000 10,003,000 8,703,000 -174,298,000 8,040,000 7,293,000 -476,000 7,670,000 1,702,000 5,620,000 8,992,000 -24,595,000 -7,752,000 2,521,000 -3,681,000 -10,485,000 -5,998,000 -5,362,000 -18,434,000 -23,870,000 -26,244,000 -12,148,000 -17,093,000 -1,441,000 4,306,000 1,282,000 10,569,000 3,644,000 10,846,000 7,222,000 -9,450,000 2,653,000 1,632,000 -983,000 -57,000 -13,451,000 -13,904,000 -13,300,000 -83,096,000 -4,471,000 -4,254,000 993,000 18,760,000 15,664,000 17,375,000 11,193,000 18,742,000 14,463,000 15,634,000 21,886,000 22,997,000 19,280,000 15,854,000 14,770,000 8,234,000 10,840,000 7,782,000 16,000 202,000 -8,787,000 -12,004,000 6,687,000 6,746,000 7,383,000 
      adjustments to reconcile net income to net cash from operations:
    		                                                                 
      loss on divestitures
    		                                                                 
      depreciation and amortization
    		6,261,000 6,172,000 5,802,000 5,726,000 6,969,000 7,424,000 7,411,000 7,865,000 7,704,000 7,908,000 7,895,000 8,351,000 9,696,000 10,111,000 10,452,000 10,216,000 10,516,000 10,663,000 10,830,000 11,128,000 11,271,000 11,462,000 11,453,000 12,253,000 11,821,000 11,632,000 11,438,000 11,553,000 11,591,000 11,484,000 11,271,000 10,759,000 9,754,000 9,857,000 9,387,000 9,534,000 9,220,000 9,628,000 9,573,000 11,249,000 11,599,000 10,542,000 10,527,000 11,302,000 10,882,000 10,954,000 8,415,000 8,598,000 7,790,000 8,018,000 7,809,000 7,587,000 7,145,000 6,430,000 6,628,000 7,084,000 6,587,000 6,711,000 7,248,000 6,797,000 7,166,000 6,927,000 9,060,000 4,450,000 2,614,000 
      stock-based compensation expense
    		1,541,000 1,411,000 1,185,000 1,128,000 997,000 1,627,000 1,495,000 1,671,000 1,669,000 1,560,000 1,738,000 1,759,000 1,904,000 1,730,000 1,468,000 2,205,000 2,448,000 1,994,000 1,279,000 1,709,000 1,792,000 1,485,000 1,592,000 2,265,000 2,501,000 1,905,000 4,969,000 1,864,000 3,649,000 2,559,000 2,289,000 2,385,000 2,584,000 3,038,000 2,836,000 3,191,000 3,252,000 2,639,000 2,974,000 3,688,000 4,004,000 3,546,000 2,964,000 2,665,000 2,316,000 1,973,000 2,076,000 2,024,000 1,620,000 1,383,000 1,139,000 1,331,000 1,090,000 975,000 977,000 969,000 1,060,000 870,000 1,175,000 1,072,000 763,000 427,000 1,094,000 1,164,000 1,073,000 
      benefit from deferred income taxes
    		3,198,000 3,247,000 2,917,000 1,986,000 -20,094,000 -645,000 -1,551,000 549,000 -115,000 -190,000 -726,000 2,333,000 1,201,000 -1,716,000 -5,202,000 -1,491,000 -120,000 -1,167,000 1,569,000 173,000 -7,605,000 -8,617,000 -2,801,000 -3,463,000 727,000 -1,076,000 -438,000 2,385,000 -2,392,000 -138,000 381,000 -6,861,000 183,000 -1,127,000 -2,545,000 6,557,000 -3,751,000 582,000 -36,000 11,737,000 -9,035,000 -4,980,000 1,775,000 -33,000 -812,000 534,000 6,012,000 -4,832,000 97,000 81,000 10,260,000 6,366,000 2,430,000 7,567,000 4,479,000 4,149,000 6,255,000 3,147,000 802,000 -1,462,000 -2,660,000 -3,596,000 2,643,000 -402,000 2,502,000 
      credit loss expense
    		0 13,000 6,000 -300,000 -42,000 903,000 137,000 382,000 363,000 192,000 272,000 318,000 274,000 262,000 185,000 238,000 196,000 180,000 50,000 123,000 578,000 706,000 20,000                                           
      gain on sale of assets
    		-646,000 -734,000 -823,000 -1,885,000 -1,363,000 -659,000 -390,000 -728,000 -527,000 -1,095,000 -554,000 -259,000 -549,000 -395,000 -1,606,000 -319,000 -1,505,000 -2,075,000 -3,283,000 -3,615,000 -753,000 -1,130,000 -1,033,000 -5,022,000 -651,000 -2,789,000 -2,339,000 -1,269,000 -181,000 12,000 -383,000 -582,000 -3,630,000 -419,000 -847,000 -489,000 -490,000   -424,000 -412,000        -140,000 244,000 608,000 139,000    6,000 -537,000 348,000 985,000   -224,000  -163,000  
      gain on insurance recovery
    		   0 0 0 -874,000         0                                                  
      amortization of original issue discount and debt issuance costs
    		81,000 244,000 69,000 98,000 625,000 129,000 131,000 132,000 135,000 136,000 138,000 147,000 137,000 409,000 178,000 645,000 994,000 986,000 1,082,000 1,190,000 1,161,000 1,228,000 1,573,000 1,599,000 1,616,000 1,492,000 1,481,000 1,435,000 1,432,000 1,334,000 1,309,000 1,277,000 1,389,000 1,349,000 1,330,000                               
      change in assets and liabilities:
    		                                                                 
      increase in receivables
    		3,821,000 3,732,000 -10,015,000 -14,278,000   -3,140,000 30,895,000 -5,407,000   -15,958,000 -21,144,000   -34,901,000 -20,788,000       23,117,000 10,482,000 1,283,000 5,300,000 9,143,000 -15,346,000 4,743,000 -5,928,000 -210,000 -24,900,000 -25,593,000 -23,019,000     1,551,000 7,102,000 67,877,000 45,869,000  2,527,000 -20,969,000   13,646,000 -24,439,000 -77,700,000 -25,269,000 -31,271,000 -1,063,000 -21,261,000 -401,000 -21,443,000 -32,724,000     -18,571,000   
      decrease in inventories
    		1,411,000 -1,492,000 5,088,000                6,694,000  19,054,000 2,046,000 5,466,000              6,387,000 8,351,000 10,630,000               1,453,000    9,183,000        
      increase in other assets
    		-1,787,000 -1,668,000 -256,000 -2,886,000 497,000   2,440,000 1,054,000   3,121,000 1,220,000   1,809,000 -299,000 -3,511,000 1,275,000 2,226,000 2,382,000 -4,650,000 -644,000 2,589,000 1,437,000 -4,785,000 -273,000  1,941,000   2,607,000 1,152,000     -3,871,000 1,667,000 3,575,000 77,000 -2,196,000 -265,000  2,183,000 -2,382,000 -543,000 2,728,000 -1,071,000 -1,755,000 4,792,000 503,000    -900,000 -297,000 -261,000 -249,000      -2,775,000 
      increase in accounts payable
    		-357,000   -10,000 11,851,000   -13,886,000 3,274,000 -13,220,000 -1,233,000 -13,970,000 12,543,000 962,000 11,246,000 11,049,000 3,948,000 9,907,000 11,437,000     3,488,000 -18,013,000 21,356,000 -15,149,000 -4,657,000 447,000 -11,852,000 18,511,000 -3,843,000 2,406,000       6,798,000 -28,000     4,179,000 10,797,000 11,610,000 -17,713,000 9,008,000 1,532,000 23,802,000   -3,828,000 -9,104,000   16,201,000 172,000   11,705,000 -2,661,000 -2,013,000 
      increase in accrued liabilities and other
    		   -2,674,000    -641,000    21,000 4,876,000   5,347,000 5,894,000   -3,512,000        5,721,000 6,535,000 7,842,000 -17,168,000 2,207,000 8,736,000 39,954,000 3,731,000     -26,861,000 8,005,000 -5,916,000 -9,250,000 12,240,000 -3,812,000 4,747,000     362,000 1,618,000 4,375,000 -9,648,000 5,430,000 7,102,000 3,692,000 3,470,000 -89,000 -1,298,000 -2,034,000 -10,558,000 5,189,000 -971,000 2,987,000 
      net cash from operating activities
    		24,716,000 21,440,000 8,828,000 -4,127,000 2,765,000 27,581,000 11,950,000 36,159,000 26,994,000 7,404,000 29,444,000 3,072,000 -5,082,000 -25,801,000 2,790,000 -16,683,000 -12,167,000 -1,936,000 27,773,000 15,498,000 15,280,000 20,625,000 4,388,000 19,100,000 18,946,000 31,971,000 2,269,000 43,287,000 -571,000 20,554,000 133,000 22,618,000 -6,547,000 33,754,000 -11,444,000 -18,840,000 10,109,000 22,726,000 -2,900,000 14,350,000 25,370,000 50,201,000 31,596,000 51,794,000 28,655,000 15,240,000 29,593,000 64,830,000 22,230,000 -6,408,000 -48,285,000 13,600,000 3,230,000 17,897,000 5,368,000 18,306,000 10,171,000 -2,369,000 19,054,000 12,258,000 24,469,000 33,038,000 -8,532,000 5,386,000 26,652,000 
      cash flows from investing activities:
    		                                                                 
      capital expenditures
    		-12,714,000 -11,694,000 -10,011,000 -13,591,000 -9,472,000 -6,586,000 -13,882,000 -9,098,000 -4,787,000 -8,375,000 -6,972,000 -10,553,000 -8,205,000 -1,894,000 -7,621,000 -2,690,000 -8,626,000 -1,828,000 -8,649,000 -1,185,000 -3,954,000 -4,006,000 -6,649,000 -9,003,000 -11,937,000 -6,399,000 -17,467,000 -12,327,000 -8,356,000 -13,762,000 -10,696,000 -9,483,000 -5,244,000 -9,353,000 -7,291,000 -5,050,000 -6,738,000 -13,234,000 -13,418,000 -18,029,000 -17,062,000 -15,808,000 -18,505,000 -15,133,000 -21,290,000 -16,127,000 -9,097,000 -8,543,000 -9,013,000 -17,302,000 -8,761,000 -11,294,000 -10,654,000 -6,188,000 -4,722,000 -1,417,000 -3,966,000 -2,029,000 -1,325,000 -3,080,000 -6,599,000 -7,540,000 -5,873,000 -3,809,000 -1,695,000 
      free cash flows
    		12,002,000 9,746,000 -1,183,000 -17,718,000 -6,707,000 20,995,000 -1,932,000 27,061,000 22,207,000 -971,000 22,472,000 -7,481,000 -13,287,000 -27,695,000 -4,831,000 -19,373,000 -20,793,000 -3,764,000 19,124,000 14,313,000 11,326,000 16,619,000 -2,261,000 10,097,000 7,009,000 25,572,000 -15,198,000 30,960,000 -8,927,000 6,792,000 -10,563,000 13,135,000 -11,791,000 24,401,000 -18,735,000 -23,890,000 3,371,000 9,492,000 -16,318,000 -3,679,000 8,308,000 34,393,000 13,091,000 36,661,000 7,365,000 -887,000 20,496,000 56,287,000 13,217,000 -23,710,000 -57,046,000 2,306,000 -7,424,000 11,709,000 646,000 16,889,000 6,205,000 -4,398,000 17,729,000 9,178,000 17,870,000 25,498,000 -14,405,000 1,577,000 24,957,000 
      proceeds from divestitures, net of cash disposed
    		   0                                                              
      proceeds from sale of property, plant and equipment
    		499,000 1,502,000 1,818,000 1,809,000 1,146,000 899,000 1,143,000 757,000 648,000 1,564,000 740,000 720,000 554,000 1,368,000 575,000 4,269,000 2,522,000 1,181,000 8,027,000 1,902,000 2,534,000 4,290,000 3,673,000 6,618,000 1,408,000 3,937,000 1,771,000 1,135,000 557,000 345,000 575,000 5,514,000 1,011,000 934,000 288,000 1,223,000 764,000 1,103,000 1,450,000 659,000 720,000 846,000 298,000 658,000 377,000 213,000 40,000 452,000 363,000 8,000 88,000 154,000 214,000 66,000 424,000 -157,000 1,270,000 48,000 145,000 521,000 201,000 533,000 -12,000 98,000 255,000 
      proceeds from insurance property claim
    		   0 0           1,668,000                                                  
      other investing activities
    		0 143,000 2,946,000                                                               
      net cash from investing activities
    		-12,215,000 -6,229,000 5,418,000 -14,871,000 40,173,000 -4,302,000 -12,739,000 -7,863,000 -2,870,000 4,122,000 921,000 61,453,000 -7,651,000 -526,000 -7,046,000 -10,187,000 -6,019,000 -647,000 -622,000 717,000 -1,420,000 284,000 -2,976,000 -21,077,000 -10,529,000 -2,462,000 -15,696,000 -10,192,000 -7,799,000 -13,666,000 -24,095,000 36,961,000 -60,148,000 -38,138,000 -7,049,000 6,152,000 -10,291,000 -12,153,000 -11,968,000 -19,355,000 -31,842,000 -14,962,000 -18,207,000 -14,475,000 -20,913,000 -15,914,000 -62,132,000 -8,091,000 -8,650,000 -17,294,000 -8,673,000 -12,314,000 -36,041,000 -6,122,000 -4,298,000 -1,574,000 -2,696,000 -1,981,000 -1,180,000 -2,559,000 -6,398,000 -7,007,000 -6,518,000 -6,187,000 -23,206,000 
      cash flows from financing activities:
    		                                                                 
      borrowings on lines of credit
    		   0 90,097,000 34,883,000 52,561,000 43,387,000 49,233,000 72,806,000 76,447,000 45,789,000 85,067,000 87,232,000 69,188,000 120,142,000 68,266,000 45,824,000 51,922,000 25,807,000 30,919,000 42,159,000 74,909,000 90,890,000 101,141,000 55,296,000 80,656,000 71,812,000 72,085,000 96,560,000 107,156,000 91,367,000    381,000 1,788,000 1,789,000 2,479,000 3,858,000 2,460,000 2,812,000 1,906,000 56,382,000 88,510,000 71,102,000 141,558,000 49,022,000 87,895,000 85,951,000 21,728,000 3,635,000 1,063,000 1,193,000 8,376,000 34,094,000 53,618,000 45,409,000        
      payments on lines of credit
    		   0 -123,215,000 -52,444,000 -48,633,000 -47,934,000 -62,222,000 -77,223,000 -90,212,000 -91,337,000 -69,635,000 -64,712,000 -65,202,000 -58,443,000 -49,663,000 -43,547,000 -56,922,000 -41,341,000 -64,233,000 -57,259,000 -58,948,000 -93,350,000 -100,946,000 -79,793,000 -61,524,000 -98,466,000 -82,320,000 -90,572,000 -81,224,000 -72,300,000    -7,059,000 -2,176,000 -183,000 -4,851,000 -2,616,000 -3,979,000 -3,555,000 -2,394,000 -84,462,000 -79,931,000 -78,748,000 -83,723,000 -86,988,000 -75,601,000 -50,632,000 -4,197,000 -3,125,000 -297,000 -2,332,000 -75,887,000 -54,944,000 -61,218,000 -39,564,000        
      debt issuance costs
    		-14,000   0        -500,000 -2,000   0 -99,000 0 -196,000     0 -297,000 10,000 -927,000 0 -138,000   -613,000 -7,000 -178,000 -157,000 -3,260,000 -436,000   -260,000 -66,000 -241,000 -1,456,000                       
      purchases of treasury stock
    		-3,404,000 -8,481,000 -10,810,000 -1,000 -172,000   -6,039,000 -6,260,000 -6,960,000 -15,006,000 -17,629,000 -82,000 -2,533,000 -4,000 -13,000 -85,000 -1,344,000 -6,000 -1,000 -6,000 -294,000 -32,000 -59,000 -4,313,000 -12,352,000 -5,013,000 -59,000 -737,000 -3,032,000 -42,000 -478,000 -379,000 -2,334,000 -48,000 10,000 -143,000   -512,000 -2,000                         
      proceeds from employee stock plans
    		   122,000 0 0 17,000 427,000                78,000 146,000 760,000 330,000 61,000 113,000 3,347,000 353,000 317,000 590,000 1,306,000 211,000 217,000 504,000   84,000 110,000 54,000 305,000 1,174,000 3,120,000 3,808,000 52,000 539,000 234,000 234,000 1,820,000 225,000 1,456,000 87,000 32,000 2,657,000 854,000 48,000 39,000 0 1,000 103,000    
      other financing activities
    		-935,000 -839,000 -865,000 -6,177,000 -2,498,000 -3,684,000 -3,356,000 -8,720,000 -86,000 -1,365,000 -1,499,000 -1,076,000 -2,547,000 3,007,000 -2,711,000 -3,528,000 -1,266,000 2,369,000 -1,561,000 -1,526,000 -1,451,000 3,698,000 -1,218,000 -1,595,000 -1,422,000 3,927,000 -1,169,000 -1,539,000 -375,000 3,060,000 -545,000 -1,322,000 -846,000 2,704,000 -371,000 -1,095,000 -718,000 2,173,000 -3,000 22,000 -208,000 -1,475,000 -12,000 14,000 -1,000 -38,000  5,000 -63,000 10,000  -125,000              
      net cash from financing activities
    		-2,856,000 -10,117,000 -11,675,000 -6,056,000 -35,838,000 -25,577,000 589,000 -18,879,000 -19,156,000 -12,742,000 -30,270,000 -64,753,000 12,801,000 25,751,000 1,271,000 19,591,000 15,127,000 3,302,000 -16,612,000 -17,061,000 -34,771,000 -27,045,000 936,000 -4,036,000 -5,691,000 -32,152,000 12,353,000 -28,191,000 -11,372,000 9,352,000 25,698,000 -66,281,000 62,858,000 1,498,000 -365,000 11,129,000 -1,181,000 983,000 -11,581,000 780,000 -1,685,000 -4,190,000 -1,635,000 -27,089,000 9,688,000 -3,876,000 42,837,000 -48,295,000 -16,654,000 27,965,000 19,234,000 -1,446,000 1,688,000 -1,138,000 70,162,000 -18,230,000   -11,837,000 -10,358,000 -19,658,000 -24,412,000 14,938,000 -1,048,000 363,000 
      effect of exchange rate changes on cash
    		-19,000 84,000 26,000 -93,000 842,000 -200,000 -761,000 1,080,000 -836,000 -43,000 375,000 1,376,000 -671,000 -1,036,000 -376,000 -430,000 -758,000 291,000 -882,000 840,000 903,000 -137,000 -2,576,000 1,127,000 -1,401,000 456,000 -581,000 -534,000 -872,000 -3,738,000 812,000 0 341,000 1,247,000 856,000 -2,427,000 79,000 -942,000 1,845,000 -2,487,000 -1,250,000 516,000 -5,114,000 1,134,000 -1,095,000 -586,000 1,091,000 -1,819,000 1,537,000 859,000 69,000 -1,242,000 61,000 1,719,000 -324,000 1,387,000 -596,000 -539,000 -802,000 247,000 -1,011,000 -562,000    
      net increase in cash, cash equivalents, and restricted cash
    		9,626,000 5,178,000 2,597,000 -25,147,000   -961,000 10,497,000   470,000  -603,000 -1,612,000 -3,361,000  -3,817,000 1,010,000 9,657,000       -2,187,000 -1,655,000  -20,614,000 12,502,000 2,548,000                                   
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 18,237,000  0 0 38,901,000  0 0 25,061,000  0 0 29,489,000  0 0 30,348,000  0 0 56,863,000  0 0 64,266,000  0 0 65,460,000                                   
      cash, cash equivalents, and restricted cash at end of period
    		9,626,000 5,178,000 20,834,000  7,942,000 -2,498,000 37,940,000  4,132,000 -1,259,000 25,531,000  -603,000 -1,612,000 26,128,000  -3,817,000 1,010,000 40,005,000  -20,008,000 -6,273,000 56,635,000  1,325,000 -2,187,000 62,611,000  -20,614,000 12,502,000 68,008,000                                   
      decrease in accrued liabilities and other
    		 -508,000 -4,626,000   -45,000 -6,545,000   -587,000 -8,221,000    -7,452,000    -1,002,000   -2,446,000 -815,000  2,207,000 4,515,000 -14,527,000            -19,349,000         8,162,000 -8,395,000 -2,852,000                
      proceeds from divestitures
    		 3,820,000 10,665,000     478,000 1,269,000 10,933,000 7,153,000                                                       
      decrease in accounts payable
    		  -522,000    -306,000                -9,842,000            -1,692,000  -3,521,000 -692,000 -20,028,000    -29,353,000           -3,895,000    -1,134,000    -30,958,000    
      (gain) loss on divestitures
    		                                                                 
      impairments and other non-cash charges
    		       3,540,000 0   0        12,048,000                3,030,000 876,000                             
      increase in inventories
    		   265,000 -2,677,000 3,908,000 8,250,000 4,416,000 1,280,000 430,000 -3,870,000 11,813,000 -20,062,000 -23,848,000 -14,812,000 -7,800,000 -2,327,000       -11,174,000 8,005,000 -6,271,000 10,139,000 4,477,000 -13,370,000 -3,618,000 -17,841,000 2,251,000 -6,848,000 -9,671,000 -829,000     10,119,000 8,386,000 -4,816,000 7,620,000   -1,280,000 -22,312,000 -5,576,000 11,274,000 -12,144,000 -20,208,000 -25,940,000   -4,985,000 1,032,000       -29,964,000 -11,422,000 1,131,000 
      proceeds from term loan
    		           0 0   0 0 0 8,258,000                                               
      cash, cash equivalents, and restricted cash at beginning of year
    		                                                                 
      cash, cash equivalents, and restricted cash at end of year
    		                                                                 
      decrease in receivables
    		          27,287,000    5,795,000    2,414,000  10,494,000 55,858,000 10,652,000              13,354,000 -9,600,000 27,606,000                           
      net decrease in cash, cash equivalents, and restricted cash
    		                   -6,000 -20,008,000 -6,273,000 -228,000 -4,886,000                                          
      decrease in other assets
    		      39,000    1,098,000    17,000                129,000    521,000                           2,543,000    
      gain on divestitures
    		                                                                 
      loss on extinguishment of debt
    		                  790,000    915,000                                           
      business acquisitions, net of cash acquired
    		                           0 0       -659,000                              
      purchases of convertible notes
    		               0 -10,030,000 0 -18,107,000 0 0 -15,349,000 -13,775,000                                           
      payment on convertible notes
    		                                                                 
      proceeds from financing obligation
    		               0                                                  
      (gain) loss on extinguishment of debt
    		               0 210,000                                                 
      impairment
    		                                                                 
      inventory impairments
    		                                                                 
      gain on extinguishment of debt
    		                   0 0               279,000 0 0 -1,894,000                           
      refund of proceeds from sale of a business
    		                           0 0 0 -13,974,000                                   
      goodwill impairment
    		                                                                 
      net benefit from doubtful accounts
    		                       748,000 255,000 403,000 386,000 141,000 1,479,000 888,000 341,000 95,000 -26,000 746,000 666,000 384,000 450,000 1,054,000 528,000 710,000 143,000 312,000 721,000 1,000 12,000 208,000 427,000 209,000 659,000 414,000                
      loss on sale of a business
    		                                                                 
      payment on 2017 convertible notes
    		                                                                 
      proceeds from 2021 convertible notes
    		                                                                 
      purchases of 2017 convertible notes
    		                                                                 
      excess tax benefit from stock-based compensation
    		                                          -16,000                       
      cash paid (received) for:
    		                                                                 
      income taxes
    		                               4,277,000 6,964,000 -33,482,000 1,845,000 714,000 587,000 -23,565,000 1,555,000 -1,112,000 2,841,000 4,291,000 4,846,000 7,166,000 10,177,000 4,294,000 7,138,000 11,534,000 10,214,000 -4,378,000 8,923,000 9,372,000 7,798,000 3,582,000 2,039,000 1,107,000 3,117,000 1,132,000 786,000 1,370,000 1,170,000 1,853,000 883,000 2,099,000 927,000 
      interest
    		                               4,333,000 342,000 3,880,000 163,000 4,471,000 188,000 3,649,000 494,000 3,744,000 308,000 3,751,000 661,000 562,000 4,154,000 331,000 3,690,000 559,000 4,006,000 100,000 4,019,000 173,000 3,368,000 234,000 1,532,000 1,950,000 2,205,000 2,269,000 3,042,000 1,703,000 1,393,000 1,426,000 2,412,000 5,419,000 4,076,000 
      increase in restricted cash
    		                                -55,915,000 -29,719,000 -46,000  -556,000   -1,985,000                          
      purchase of 2017 convertible notes
    		                                                                 
      net decrease in cash and cash equivalents
    		                                -3,496,000 -1,639,000 -18,002,000                               
      cash and cash equivalents at beginning of year
    		                                0 0 87,878,000 0 0 0 107,138,000 0 0 0 85,052,000 0 0 46,846,000 0 0 0 25,247,000             0   
      cash and cash equivalents at end of period
    		                                -3,496,000 -1,639,000 69,876,000  -1,284,000 10,614,000 82,534,000  -9,407,000 31,565,000 91,692,000 11,364,000 16,335,000 41,710,000  6,625,000    -1,402,000 -31,062,000 95,366,000  -111,000 -53,000 12,266,000  -412,000 -2,598,000 9,309,000   3,929,000 
      purchase of convertible notes due 2017
    		                                                                 
      cash paid for:
    		                                                                 
      gain on sale of a business
    		                                                                 
      decrease (increase) in restricted cash
    		                                                                 
      proceeds from sale of a business
    		                                                                 
      proceeds from convertible notes due 2021
    		                                                                 
      purchases of convertible notes due 2017
    		                                                                 
      net increase (decease) in cash and cash equivalents
    		                                                                 
      cash and cash equivalents at end of year
    		                                                 30,369,000             -2,636,000   
      decrease (increase) in other assets
    		                                                     285,000            
      purchase of senior notes
    		                                    0 0 -9,206,000                           
      net increase in cash and cash equivalents
    		                                    -1,284,000 10,614,000 -24,604,000 -6,712,000 -9,407,000 31,565,000 6,640,000 11,364,000 16,335,000 -5,136,000 11,389,000 6,625,000 -1,537,000 5,122,000 -37,655,000 -1,402,000 -31,062,000 12,356,000 70,908,000 -111,000 -53,000 732,000 5,235,000 -412,000 -2,598,000 1,057,000 -2,636,000   
      (gain) loss on sale of assets
    		                                      -1,271,000    11,000 -114,000 -224,000 -99,000        -17,000         100,000   
      decrease (increase) in inventories
    		                                           -1,091,000               7,003,000 15,521,000 7,138,000 5,520,000    
      post-closing payment for business acquisition
    		                                              0 0   0               
      purchase of treasury stock
    		                                           -2,217,000   -15,058,000 -10,873,000 -17,227,000 -7,598,000 -45,000 -1,000 -503,000 -95,000 0 0 -67,000 -86,000 -56,000 0 -10,000 -202,000 -157,000   
      impairment charges
    		                                                                 
      decrease (increase) in receivables
    		                                              11,601,000            -14,057,000 -8,255,000 37,278,000 74,374,000    
      principal payments on notes payable and long-term debt
    		                                                      -30,115,000 -37,000 -119,000 -186,000 -10,140,000 -104,000 -99,000 -96,000 -10,136,000   
      proceeds from senior notes, net of offering costs
    		                                                                 
      loss on sale of assets
    		                                                                 
      business acquisition, net of cash acquired
    		                                                  0 -1,174,000              
      benefit from doubtful accounts
    		                                                      -124,000 60,000 303,000 239,000 -56,000 824,000 946,000 587,000 912,000 752,000 6,000 
      cash and cash equivalents at beginning of period
    		                                                   0 0 83,010,000  0 0 11,534,000  0 0 8,252,000   -238,000 
      non-cash impairment charges
    		                                                      0 75,000   75,000       
      net (recovery) benefit from doubtful accounts
    		                                                     -44,000            
      other borrowings
    		                                                     9,000            
      net income from discontinued operations
    		                                                              3,604,000   
      net operating activities of continuing operations
    		                                                          19,054,000 12,258,000 24,469,000 33,038,000 4,821,000 2,723,000 15,261,000 
      net operating activities of discontinued operations
    		                                                              -13,353,000 2,663,000 11,391,000 
      business acquisitions
    		                                                               -1,284,000  
      net investing activities of continuing operations
    		                                                              -7,069,000 -4,995,000 -23,359,000 
      net investing activities of discontinued operations
    		                                                               -1,192,000  
      net financing activities of continuing operations
    		                                                          -11,837,000 -10,358,000 -19,658,000 -24,412,000 14,938,000 -858,000  
      net financing activities of discontinued operations
    		                                                              0 -190,000  
      long-term borrowings
    		                                                             740,000    
      net cash from in financing activities
    		                                                         5,621,000        
      net income on disposal of discontinued operations
    		                                                               -560,000  
      net (payments) borrowings on lines of credit
    		                                                            -18,810,000 -24,957,000   14,789,000 
      net payments on lines of credit
    		                                                              25,218,000   
      non-cash charges
    		                                                                 
      insurance proceeds from property, plant and equipment claim
    		                                                                 
      excess tax benefit from exercise of stock options
    		                                                                 
      proceeds from exercise of stock options and espp
    		                                                               227,000 314,000 
      effect of exchange rate changes
    		                                                               178,000 358,000 
      net borrowings (payments) on lines of credit
    		                                                                 
      net (income) income from discontinued operations
    		                                                               -668,000  
      net borrowings on lines of credit
    		                                                                 
      preferred stock dividends paid in cash
    		                                                                 
      decrease (increase) in accounts and notes receivable
    		                                                                 
      proceeds from long-term financing
    		                                                                 
      payments on notes payable and long-term debt
    		                                                                -13,758,000 
      increase in accounts and notes receivable
    		                                                                 
      depreciation
    		                                                                 
      amortization
    		                                                                 
      benefit for deferred income taxes
    		                                                                 
      impairment losses
    		                                                                 
      change in assets and liabilities, net of acquisitions:
    		                                                                 
      decrease in restricted cash
    		                                                                 
      net cash from operations
    		                                                                 
      acquisitions, net of cash acquired
    		                                                                 
      payment received on former shipyard operation note receivable
    		                                                                 
      tax benefit from exercise of stock options
    		                                                                 
      impairment loss
    		                                                                 
      acquisitions, net of cash received
    		                                                                 
      net (payments) borrowings on notes payable and long-term debt
    		                                                                 
      excess tax benefit from exercise of stock options and vesting of share awards
    		                                                                 
      preferred stock dividends
    		                                                                 
      acquisition, net of cash acquired
    		                                                                 
      decrease in accounts and notes receivable
    		                                                                 
      payments received on notes receivable
    		                                                                 
      proceeds from espp and exercise of stock options
    		                                                                 
      net proceeds from common stock issue
    		                                                                 
      repurchase of preferred stock
    		                                                                 
      decrease (increase) in accounts receivable
    		                                                                 
      net borrowings (payments) on notes payable and long-term
    		                                                                 
      decrease restricted cash
    		                                                                 
      impairment of long-lived assets
    		                                                                 
      proceeds from public offering, net of cash
    		                                                                 
      net borrowings (payments) on line of credit
    		                                                                 
      net proceeds from preferred stock issue
    		                                                                 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                 
      gain on sale of property, plant and equipment
    		                                                                 
      change in assets and liabilities, net of effects of acquisitions:
    		                                                                 
      proceeds from disposal of property, plant and equipment
    		                                                                 
      net borrowings from notes payable
    		                                                                 
      proceeds from public offering, net of costs
    		                                                                 
      cash and cash equivalents at end of the period
    		                                                                 
      proceeds from exercise of stock options
    		                                                                 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.